Summary
TWO drugs to treat bladder and lung cancer should not be approved for use on the NHS, a health watchdog has said.
The National Institute for Health and Clinical Excellence (Nice) is not recommending Tarceva (erlotinib) as a maintenance treatment for people with non-smallcell lung cancer that is stable following chemotherapy.See the full content of this document
Extract
Watchdog Refuses Two Drugs to Treat Cancer
It also turned down Javlor (vinflunine) for advanced bladder cancer. Both pieces of guidance ar...
See the full content of this document
Sponsored links
